{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:51:16Z","timestamp":1790945476155,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cad.0b013e32832ec041","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T03:37:30Z","timestamp":1248320250000},"page":"723-735","source":"Crossref","is-referenced-by-count":61,"title":["The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells"],"prefix":"10.1097","volume":"20","author":[{"given":"Christina W.","family":"Yde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias P.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin V.","family":"Bennetzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Lykkesfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole G.","family":"Mouritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02841869609083961","article-title":"Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer","volume":"35","author":"Lykkesfeldt","year":"1996","journal-title":"Acta Oncol"},{"issue":"1","key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10549-005-9036-4","article-title":"Endocrine therapy \u2013 current benefits and limitations","volume":"93","author":"Nicholson","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.03.016","article-title":"Pathways to tamoxifen resistance","volume":"256","author":"Riggins","year":"2007","journal-title":"Cancer Lett"},{"key":"R4-10-20210203","first-page":"CD000284","article-title":"Chlorpromazine versus placebo for schizophrenia","volume":"2","author":"Adams","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/138945006778226543","article-title":"Evolution of antipsychotic intervention in the schizophrenic psychosis","volume":"7","author":"Garver","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1034\/j.1600-0773.2003.920207.x","article-title":"Inactivation of cholinesterase induced by chlorpromazine cation radicals","volume":"92","author":"Muraoka","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1248\/bpb.18.593","article-title":"Pharmacokinetic analysis of chlorpromazine in rat serum, cerebrospinal fluid and striatum","volume":"18","author":"Sato","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"R9-10-20210203","first-page":"107","article-title":"Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth","volume":"15","author":"Gil-Ad","year":"2006","journal-title":"Oncol Rep"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0006-2952(99)00156-2","article-title":"Effects of psychotropic drugs on cell proliferation and differentiation","volume":"58","author":"Nordenberg","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","article-title":"Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities","volume":"31","author":"Martins","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/138945006778226660","article-title":"Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance","volume":"7","author":"Tsakovska","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00744664","article-title":"Pharmacologic circumvention of multidrug resistance","volume":"12","author":"Ford","year":"1993","journal-title":"Cytotechnology"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/138945006778226570","article-title":"Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal","volume":"7","author":"Michalak","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bjc.1995.59","article-title":"Interaction of tamoxifen with the multidrug resistance P-glycoprotein","volume":"71","author":"Callaghan","year":"1995","journal-title":"Br J Cancer"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-5793(94)00378-5","article-title":"Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells?","volume":"344","author":"Kayyali","year":"1994","journal-title":"FEBS Lett"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841869209088892","article-title":"Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1","volume":"31","author":"Lykkesfeldt","year":"1992","journal-title":"Acta Oncol"},{"key":"R18-10-20210203","first-page":"1587","article-title":"Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7\/TAMR-1","volume":"54","author":"Lykkesfeldt","year":"1994","journal-title":"Cancer Res"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1677\/erc.0.0100409","article-title":"Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens","volume":"10","author":"De Cremoux","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1017977406429","article-title":"Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways","volume":"67","author":"Lundholt","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1158\/1535-7163.MCT-07-0072","article-title":"Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death","volume":"6","author":"Yde","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-4157(00)00009-5","article-title":"Titration calorimetry of surfactant-membrane partitioning and membrane solubilization","volume":"1508","author":"Heerklotz","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1529\/biophysj.105.070987","article-title":"Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition","volume":"90","author":"Leidy","year":"2006","journal-title":"Biophys J"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1432-1033.1995.tb20352.x","article-title":"Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability","volume":"228","author":"Drori","year":"1995","journal-title":"Eur J Biochem"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0005-2736(91)90397-Q","article-title":"A general model for the interaction of foreign molecules with lipid membranes: drugs and anaesthetics","volume":"1062","author":"J\u00f8rgensen","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-2952(01)00542-1","article-title":"Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature","volume":"61","author":"Agas\u00f8sler","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0005-2736(99)00092-9","article-title":"Association of ethanol with lipid membranes containing cholesterol, sphingomyelin and ganglioside: a titration calorimetry study","volume":"1420","author":"Trandum","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bpc.2004.04.001","article-title":"ESR studies on the effect of cholesterol on chlorpromazine interaction with saturated and unsaturated liposome membranes","volume":"111","author":"Wisniewska","year":"2004","journal-title":"Biophys Chem"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","article-title":"Endocrine-responsive breast cancer and strategies for combating resistance","volume":"2","author":"Ali","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/carcin\/22.6.839","article-title":"Understanding the genotoxicity of tamoxifen?","volume":"22","author":"Phillips","year":"2001","journal-title":"Carcinogenesis"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00204-007-0188-3","article-title":"The DNA-damaging potential of tamoxifen in breast cancer and normal cells","volume":"81","author":"Wozniak","year":"2007","journal-title":"Arch Toxicol"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","article-title":"Relationship between tamoxifen use and high risk endometrial cancer histologic types","volume":"112","author":"Bland","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R33-10-20210203","first-page":"25","article-title":"Risk of endometrial cancer after tamoxifen treatment","volume":"11","author":"Morgan","year":"1997","journal-title":"Oncology (Huntingt)"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/82.21.1702","article-title":"Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol","volume":"82","author":"Clarke","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2006.09.030","article-title":"Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD\/SCID mice","volume":"459","author":"Zeisig","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/carcin\/17.8.1595","article-title":"Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy","volume":"17","author":"Bursch","year":"1996","journal-title":"Carcinogenesis"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1074\/jbc.M510249200","article-title":"Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure","volume":"281","author":"Moreira","year":"2006","journal-title":"J Biol Chem"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-008-0011-8","article-title":"Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant","volume":"114","author":"Frogne","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1677\/erc.1.00946","article-title":"Antiestrogen-resistant human breast cancer cells require activated protein kinase B\/Akt for growth","volume":"12","author":"Frogne","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canlet.2007.06.010","article-title":"Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT","volume":"256","author":"Yde","year":"2007","journal-title":"Cancer Lett"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/la061628b","article-title":"Trifluoperazine causes a disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of pH, acyl unsaturation, and proportion of PS","volume":"23","author":"Broniec","year":"2007","journal-title":"Langmuir"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bpc.2003.11.004","article-title":"Presence of anionic phospholipids rules the membrane localization of phenothiazine type multidrug resistance modulator","volume":"109","author":"Wesolowska","year":"2004","journal-title":"Biophys Chem"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32832ec041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:00Z","timestamp":1786039080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200909000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32832ec041","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}